ABSTRACT: Background. The presence of regional lymph node metastasis has an important impact on clinical management and prognostication of patients with oral tongue squamous cell carcinoma (SCC). Approximately 30% to 50% of patients with oral tongue SCC have regional metastasis at diagnosis, but the limited sensibility of the current diagnostic methods used for neck staging does not allow detection of all cases, leaving a significant number of undiagnosed metastasis (occult lymph node metastasis). In this study, we evaluated whether clinicopathologic features and immunohistochemical detection of carcinomaassociated fibroblasts (CAFs) and activin A could be predictive markers for occult lymph node metastasis in oral tongue SCC. Methods. One hundred ten patients with primary oral tongue SCC, who were classified with early stage tumor (stage I and II) and received surgical treatment with elective neck dissection, were enrolled in the study.
INTRODUCTION
Oral tongue squamous cell carcinomas (SCCs) are locally aggressive and frequently show lymph node metastasis at diagnosis. Regional lymph node metastasis is considered the most reliable marker for therapy and prognosis of oral tongue SCC, and the knowledge of this prognostic factor before treatment is essential in determining the best therapeutic choice for the patient. However, independent of the neck staging method, the indices of occult neck lymph node metastasis are high (20% to 30%) in patients with oral tongue SCC, significantly influencing its treatment and prognosis. 1 Although a variety of clinical, histopathologic, and biological markers have been proposed as predictive of occult lymph node metastasis in oral tongue SCC, none of them has yet to impact on routine clinical care. 2 Previous studies have demonstrated that increased density of carcinoma-associated fibroblasts (CAFs) in the stroma of oral tongue SCC correlated with lymph node metastasis and higher mortality. [3] [4] [5] In a recent study, we demonstrated that CAFs, indicating myofibroblast transdifferentiation, promote tumorigenesis of oral tongue SCC cell lines via upregulation of activin A, a member of the transforming growth factor-b superfamily of proteins. 6 Interestingly, overexpression of activin A in all stages of various oral SCCs was associated with increased regional lymph node metastasis and lower disease-free and overall survivals. 7 Therefore, the purpose of this study was to determine whether the presence of CAFs and the expression of activin A, as well as clinicopathological features, are predictive for occult lymph node metastasis in early stage oral tongue SCC. In the present study, we provide evidence that immunohistochemical expression of activin A is a marker of occult lymph node metastasis and shortened overall survival in patients with early stage oral tongue SCC.
MATERIALS AND METHODS

Samples
One hundred ten patients with primary oral tongue SCC, who were classified with clinically early stage tumor (stage I: T1N0M0 or stage II: T2N0M0) and received surgical treatment with elective neck dissection in the Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, Brazil, from 1980 to 2010, were enrolled in the study. For clinical stage, patients were systematically examined, including neck palpation and a cervical CT examination to warrant N0 classification, and chest X-ray or CT scan were performed to determine the presence of distant metastasis. CT scan was introduced in the routine of oral cancers initial examination in the early 1990s. In this institute, elective neck dissection is applied in patients with high-risk for occult metastasis, which is based on location in the posterior portion of the tongue or thickness >3 mm. 8 Radical neck dissection was performed until the 1990s and thus replaced for supraomohyoid dissection thereafter. The study was approved by the Ethics Committee of the A.C. Camargo Cancer Center, São Paulo, Brazil.
Histological risk model, depth of invasion, and margin status
Tissue blocks, including those of the tumors and cervical lymph nodes, were retrieved and new sections were stained with hematoxylin-eosin. Small lymph nodes showing capsule integrity were cut in half, whereas large lymph nodes or those with signs of tumor involvement were cut in several sections (2-to 3-mm sections) before histological processing. Presence of tumor cells in the lymph nodes, regardless of size, was classified as regional metastasis. All slides were assessed independently by 3 investigators who were blinded to clinicopathologic data and outcomes and any disagreement was settled by discussion. Tumors were scored regarding worst pattern of invasion, lymphocytic infiltrate, and perineural invasion, and classified according to the histological risk model proposed by Brandwein-Gensler et al. 9 Each slide was scanned using the Aperio Scanscope (Aperio Technologies, Vista, CA) and the depth of tumor invasion (tumor thickness) and the distance from resection margin were measured using the software Image Scope (Aperio Technologies). Depth of invasion represented the distance from the tumor surface to the deepest area of the tumor, and the cutoff value of 5 mm was used to categorize the tumors into 2 groups. 10 The distance from surgical margin, identified as the closest distance between the deepest portion of the tumor and the surgical resection edge, was categorized into 2 groups based on cutoff value of 5 mm, as previously described. 10 
Immunohistochemistry
Immunohistochemistry was performed on 3-mm tissue sections using the avidin-biotin-peroxidase complex method. In essence, sections were deparaffinized and dehydrated using a graded series of ethanol. Sections were then subjected to antigen retrieval with 0.01 M citrate buffer pH 6.0 in an electric pressure cooker and incubation with 3% aqueous hydrogen peroxide for 15 minutes to quench endogenous peroxidase The sections were incubated with monoclonal mouse anti-a-smooth muscle actin diluted 1:400 (Dako, Carpenteria, CA) or rabbit antiactivin A diluted 1:50 (R&D Systems, Minneapolis, MN), followed by the labeled streptavidin-biotin detection system (Dako). Reactions were developed by incubating the sections with 0.6 mg/mL 3,3 0 -diaminobenzidine tetrahydrochloride (Sigma-Aldrich, St. Louis, MO) containing 0.01% H 2 O 2 and counterstained with Mayer's hematoxylin. The control reactions were performed by the exclusion of the primary antibodies.
The presence of a-smooth muscle actin-positive cells (CAFs) was classified as negative, scanty, or abundant, as described by Kellermann et al 3 in a blinded analysis performed by 3 of the authors. Two different areas of the tumor were analyzed: the stroma within the tumor, defined as the overall area for the purposes of this study, and the deep invasive tumor front, defined as tumor front, which represented the band of tissue between the invasive tumor front and adjacent normal tissue. For statistical purposes, negative and scanty samples were lumped together and compared with samples classified as abundant presence of CAFs. For activin A, the expression was scored after the methods of Chang et al. 7 Briefly, glass slides were scanned into high-resolution images using the Aperio Scanscope CS Slide Scanner and the obtained digital images were analyzed with Pixel Count V9 algorithm (Aperio Technologies). By using specific input parameters (hue value 5 0.1; hue width 5 0.5; color saturation threshold 5 0.04; and intensity threshold ranging from 90-180), the percentage of cytoplasm positivity was calculated and classified in 3 categories according to their intensity range as weak (from 130-180), moderate (from 105-129), and strong staining (from 90-104). Each category received an intensity score, 1 for weak, 2 for moderate, and 3 for strong staining. The final score of each tumor was calculated as the sum of the percentage of each category multiplied by their intensity scores using the following formula: [(%weak 3 1) 1 (%moderate 3 2) 1 (%strong 3 3)]. The results ranged from 109 to 237, and the median value of 174 was used to divide tumors into 2 groups, below and above the median, exhibiting low and high activin A immunohistochemical expression, respectively.
Statistical analysis
Correlations between presence of occult lymph node metastasis and clinicopathologic and immunohistochemical parameters of the tumors were performed by crosstabulation and Fisher's exact test. Similarly, the immunohistochemical expression of activin A was correlated with the clinicopathologic features of the tumors. Survival curves were constructed based on the Kaplan-Meier method and compared with the log-rank test. For univariate and multivariate survival analysis, the Cox proportional hazard model was used. The level of significance considered was 5% (p .05).
RESULTS
In this cohort, a male prevalence was observed (70%) and the average age was 57.8 6 13.2 years (range, 21-84 years). Most of the patients reported smoking (78 patients) and drinking alcohol (71 patients). Regarding tumor size (T classification), 19 patients were T1 (17.3%) and 91 were T2 (82.7%). There were 29 patients (26.3%) who had occult lymph node metastasis as evidenced by the presence in pathologic findings in the elective neck dissection specimens. The histological risk model based on the Brandwein-Gensler score system classified 12 tumors (10.9%) in low risk, 53 (48.2%) in intermediate risk, and 45 (40.9%) in high risk. During follow-up, 21 patients (19%) developed local recurrence and 13 (11.8%) developed regional recurrence (11.8%). The overall survival ranged between 6 and 190 months, with a median of 42 months (mean, 51.5 months).
Dividing the tumors in relation to presence of occult lymph node metastasis, we found that high immunohistochemical expression of activin A was significantly associated with the risk of occult lymph node metastasis (p 5 .006; Table 1 ). From tumors with occult lymph node metastasis, 74.1% (n 5 20) were classified as expressing high levels of activin A. Immunoreactivity for activin A was observed as a cytoplasmatic stain with variable distribution and intensity in the tumor cells (Figure 1 ). Immunopositivity was also found in scattered stromal cells, including inflammatory cells, CAFs, and endothelial cells. Presence of occult lymph node metastasis was not associated with clinical features, histological risk, or its individual parameters (data not shown), depth of invasion, distance from surgical margin, or abundance of CAFs within tumor stroma and front ( Table 1) . Lack of CAFs was observed in 36.4% (n 5 40) of the tumors, but all samples demonstrated positivity for a-smooth muscle actin in the smooth muscle of the blood vessel walls, which worked as an internal positive control. In the tumor front, absence of CAFs was found in 45.6% (n 5 50) of the tumor samples ( Figure 2) . Interestingly, depth of invasion was significantly associated with presence of CAFs (p 5 .0001; Figure 3 ). In the univariate analysis, sex of the patient, smoking habit, drinking habit, occult lymph node metastasis, local recurrence, regional recurrence, depth of tumor invasion, and activin A immunohistochemical expression were positively associated with lower overall survival ( (Figure 4) . However, in the adjusted multivariate analysis, based on Cox proportion regression, only presence of occult lymph node metastasis (p 5 .009), local recurrence (p 5 .003), regional recurrence (p < .0001), and immunohistochemical expression of activin A (p 5 .012) remained as significant predictors of overall survival of patients with early stage oral tongue SCC (Table 2) .
Interestingly, the predictive hazard ratio (HR) of activin A immunohistochemical expression dropped from 3.81 in the univariate analysis to 2.44 in the multivariate, suggesting the influence of other factors on determination of the activin A hazard risk. To identify possible cofounds of activin A, we determined whether activin A expression is associated with clinicopathologic features of patients with oral tongue SCC. As depicted in Table 3 , a high expression of activin A was significantly associated with regional recurrence (p 5 .01), as well as presence of occult lymph node metastasis (p 5 .006). Although not statistically significant, the association of activin A with histological risk reached a p value of .06 and with the presence of CAFs in the tumor front a p value of .07 (Table 3) . Thus, these data show an association between activin A immunohistochemical expression and regional recurrence, and strongly suggest an important influence on survival of patients with oral tongue SCC.
DISCUSSION
Nodal status is one of the most important prognostic factors for oral tongue SCCs and has a significant impact on survival rates. Occult lymph node metastases are frequently observed in patients with oral tongue SCC and elective neck dissection, in general, is advocated for the majority of the patients, except for those with very superficial tumors. 8, 11 In this scenario, with a lack of strong predictive factors of lymph node disease, several patients who do not present lymph node metastasis are overtreated by neck dissection, whereas other patients may not have the neck treated but show occult neck disease. In both situations, the impact of the decision is fundamental for the patient's survival and quality of life. In this cohort, 29 patients (26.3%) clinically classified as N0 presented metastatic disease, revealing that 81 (73.7%) were overtreated by neck dissection, leaving considerable functional and esthetic sequel. The frequency of occult lymph node metastasis in this study was in the range to that reported by other studies. [11] [12] [13] [14] [15] Thus, the identification of predictive factors for occult lymph node metastasis will have a significant impact on treatment and survival of patients with oral tongue SCC.
Herein, we demonstrated that the immunohistochemical expression of activin A was significantly associated with identification of patients with occult lymph node metastasis and, more importantly, multivariate analysis showed that activin A overexpression was an independent marker for overall survival in early stage oral tongue SCC after adjusting for other prognostic factors. Activin A is a member of the transforming growth factor-beta (TGF-b) superfamily, and shares the same intracellular signaling pathways (Smad and mitogen-activated protein kinase) with other TGF-b family members. 16 Activin A shows pleiotropic effects in many cell types including growth, differentiation, and survival, although it was initially discovered in ovarian follicular fluid as a promoter of pituitary follicle-stimulating hormones. 17, 18 Aberrant expression of activin A has been described in several types of cancer, and recent studies have started to elucidate its causal role on tumorigenesis. In prostate cancers, overproduction of activin A by tumor cells leads to increased angiogenesis, decreased immune surveillance, and increased epithelial-to-mesenchymal transition of the tumor cells, favoring tumor progression. 19 Overexpression of activin A in endometrial and esophageal carcinomas and malignant pleural mesotheliomas was associated with an induction of the proliferation via regulation of cyclin D. [20] [21] [22] Furthermore, activin A in the serum of patients with breast and prostate cancer with bone metastases are significantly higher than those of patients without bone metastases. 23 In addition, the activin A mRNA level was significantly associated with lymph node metastasis and clinical stage in esophageal carcinoma, and patients with high expression of activin A had a poor prognosis compared to those with low expression levels. 24 Few studies have suggested that activin A plays a role in oral tumorigenesis. The first evidence of the participation of activin A in oral cancer came from the study of Shimizu et al 25 in 2007. Those authors, by using chromosomal comparative genomic hybridization and oligonucleotide microarrays in head and neck cell lines, identified the upregulation of INHBA, the gene encoding activin A. Further analysis demonstrated that the expression of activin A was significantly higher in tumor samples compared with matched normal samples, and its expression in tumors was associated with lymph node metastasis and shortened disease-free survival. 25 Later, Chang et al 7 confirmed that the high percentage of activin A-positive cells in oral carcinomas was significantly associated with clinicopathologic features, including N classification, tumor cellular differentiation, and presence of perineural invasion, and with worse prognosis as revealed by shortened overall and disease-free survival. Moreover, downregulation of activin A expression with small interference RNA reduced proliferation and invasion of oral cancer cells. 7 In the present study, a strong association between activin A expression and risk of occult lymph node metastasis was observed, and by using logistic regression analysis we were able to confirm that activin A, although in strong association with risk of regional recurrence after treatment, is an independent prognostic factors for the survival of patients with oral tongue SCC. Taken together, our results demonstrate for the first time that immunodetection of activin A is helpful as an indicator of subclinical disease of the neck, and reinforce the suggested role of activin A on tumor progression and metastasis.
After our first study demonstrating that abundant presence of myofibroblasts in oral carcinomas, particularly in the invasive tumor front, leads to a more aggressive behavior, such as shorter overall survival, 3 several studies attended to elucidate its role in oral cancer development and progression. In general, those studies replicated our findings revealing that high density of CAFs (myofibroblasts) is a strong predictor of poor prognosis, 4, 5, [26] [27] [28] and further showed that CAFs in the stroma of oral carcinomas may influence proliferation and invasion, resulting in a more aggressive tumor. 6, 29 Interestingly, in line with a recent study analyzing the disease-specific survival of patients with early stage oral tongue SCC, 30 our findings do not support the association between CAFs, either in the stroma within the tumor or in the invasive tumor front, and risk for occult lymph node metastasis or survival of patients with early stage oral tongue SCC. A possible explanation for this lack of association resides in the cross-talk between tumor cells during invasion and resident normal stroma cells. CAFs, a-smooth muscle actinpositive cells, are not found in the stroma of normal oral mucosa and dysplastic lesions, 3, 31, 32 but it is found in approximately 60% of the oral tongue SCCs in contact with the tumor islands. [3] [4] [5] 27 Moreover, in vitro studies demonstrated that TGF-b1 released by oral carcinoma cells induces myofibroblast transition, 4, 33 suggesting that the emergence of CAFs within tumor stroma is coordinated by tumor cell invasion. In support for this hypothesis, the majority of samples classified as CAF-negative were those with the shortest depth of invasion, whereas high CAF density was found in tumors with more than 5 mm of invasion.
Many histopathologic features have been described as predictive of occult lymph node metastasis in oral tongue SCC, but none of them showed high reproducibility. [34] [35] [36] The grading system applied in the current study, the histologic risk model proposed by Brandwein-Gensler et al, 9 has demonstrated very expressive results, allowing the identification of patients with oral cancer with poor prognosis. 27, [37] [38] [39] However, its value in predicting occult lymph node metastasis was never evaluated. Our results demonstrated that this model or its individual parameters did not correlate with the presence of lymph node metastasis. A recent study demonstrated the correlation between tumor satellite distance and the presence of occult lymph node metastasis in early stage oral tongue SCC. 40 Although tumor satellite is contemplated under worst pattern of invasion in the histological risk model, the number of samples in the present cohort classified as tumor satellites was very low, not allowing any further conclusion.
In closing, our study is the first to demonstrate that activin A immunodetection correlates with occult lymph node metastasis in patients with early oral tongue SCC. Furthermore, the findings of this study reinforce that the expression of activin A is an independent marker of a patient's outcome and support its potential as a prognosticator for oral tongue SCCs. A better understanding and knowledge of the biological events that precede the clinical presentation of the cervical metastatic disease can markedly increase the survival rates of patients with oral tongue SCC.
